'Natriuretic peptides' presentation slideshows

ACC Heart Failure Guidelines Slide Set

ACC Heart Failure Guidelines Slide Set.

1.87k views • 87 slides

Program Information

Program Information. Acute Kidney Injury in the ICU. Susan L. Evans, MD Associate Director Surgical ICU Assistant Professor of Trauma, Surgical Critical Care and Acute Care Surgery The F. H. Sammy Ross Trauma Center Carolinas Medical Center Charlotte, NC.

826 views • 64 slides

HEART FAILURE AND BREATHLESSNESS IN END STAGE CARE

HEART FAILURE AND BREATHLESSNESS IN END STAGE CARE. Dr K Ranjadayalan , Consultant Cardiologist BMI The London Independent Hospital Newham University Hospital. A Breathless patient. 57 yr old Male P/C Effort Dyspnoea for 6 weeks Bilateral leg swelling P/H H/T for 4 years

567 views • 41 slides

HEART FAILURE AND BREATHLESSNESS IN END STAGE CARE

HEART FAILURE AND BREATHLESSNESS IN END STAGE CARE. Dr K Ranjadayalan , Consultant Cardiologist BMI The London Independent Hospital Newham University Hospital. A Breathless patient. 57 yr old Male P/C Effort Dyspnoea for 6 weeks Bilateral leg swelling P/H H/T for 4 years

523 views • 41 slides

NEW CONCEPTS IN VASOACTIVE THERAPY

NEW CONCEPTS IN VASOACTIVE THERAPY. Jerrold H Levy, MD Professor of Anesthesiology Deputy Chairman for Research Emory University School of Medicine Cardiothoracic Anesthesiology and Critical Care Emory Healthcare Atlanta, Georgia. VASOACTIVE THERAPY. Vasodilators. Beta Blockers

760 views • 40 slides

NEW CONCEPTS IN VASOACTIVE THERAPY

NEW CONCEPTS IN VASOACTIVE THERAPY. Jerrold H Levy, MD Professor of Anesthesiology Deputy Chairman for Research Emory University School of Medicine Cardiothoracic Anesthesiology and Critical Care Emory Healthcare Atlanta, Georgia. VASOACTIVE THERAPY. Vasodilators. Beta Blockers

599 views • 40 slides

Bio- markers in pleural effusions

604 views • 40 slides

517 views • 35 slides

Congestive Heart Failure A Real Threat

Congestive Heart Failure A Real Threat. Etiology. Systolic Dysfunction(Decreased contractility): Reduction in muscle mass(due to ishcemia&MI ) Dilated cardiomyopathies ( idiopathic,viral,alcoholic ) Ventricular Hypertrophy: Pressure overload(systemic or pulmonary hypertension,

523 views • 31 slides

Accuracy of natriuretic peptides levels in the diagnosis of left ventricular dysfunction

366 views • 22 slides

Heart Failure (CHF)

357 views • 20 slides

Drug therapy of heart failure

Drug therapy of heart failure. OBJECTIVES:. By the end of this lecture, students should be able to: - Describe the different classes of drugs used for treatment of acute & chronic heart failure and their mechanism of action Understand their pharmacological effects, clinical

182 views • 14 slides

Peptide synthesis technology with great potential

Peptide synthesis is a solid phase synthesis process generally from the n-terminal (amino terminal) to the c-terminal (carboxyl terminal) synthesis. In the past it was carried out in solution called liquid phase synthesis. in 1963, Merrifield proposed solid-phase peptide synthesis (SPPS). The process of synthesis was convenient, rapid so that it became the preferred method and brought about a revolution of the peptides in organic synthesis. Afterwards through continuous improvement and efforts, today solid-phase method has become a common technique in peptide and protein synthesis while showing unparalleled advantages compared with the classic liquid phase synthesis. For example, greatly reducing the difficulty of purifying product in each step.

63 views • 2 slides

Introduction

1.5. NS. 1.0. Pyocyanin (relative amount). 0.5. 0. PAO1. PAO1. PAO1. Vfr-. Vfr-. Vfr-. +. +. +. +. BNP. CNP. BNP. CNP. C-type natriuretic peptide (CNP) modifies quorum sensing molecules production in Pseudomonas aeruginosa PAO1.

93 views • 1 slides

Introduction

1.5. NS. 1.0. Pyocyanin (relative amount). 0.5. 0. PAO1. PAO1. PAO1. Vfr-. Vfr-. Vfr-. +. +. +. +. BNP. CNP. BNP. CNP.

102 views • 1 slides